Master Data

Registry
Register court München HRB 252108
Previous
AD HOC 19/2 GmbH
Registered
10/15/2019
Industry
Manufacture of basic pharmaceutical productsManufacture of pharmaceutical preparationsWholesale of pharmaceutical goods
Purpose
Entwicklung von therapeutischen und diagnostischen Wirkstoffen gegen CDKs (CDK - Cyclin-dependent Kinase).

History

No events found for this filter

Management

NameRole
Andreas Dr. Treml
since 12/14/2022
Managing Director
Hendrik Dr. Liebers
since 12/14/2022
Managing Director

Beneficial Owners
Beta

Identified persons (8)

NameOwnership
B******* S********
20.38%
K**** G****
18.13%
Dr. M****** T*******
11.56%

Unresolved chains (3)

NameOwnership
origenis GmbHSelf-held cycle
0.39%

Shareholders
Beta

5 shareholders

GmbH structure

4 of 5 shown

Name
Location
Amount
Share
originis GmbH
Germany
€22,500
90.00%
Simeande UG (haftungsbeschränkt)
Germany
€625
2.50%
AMspar Verwaltungsgesellschaft UG (haftungsbeschränkt)
Germany
€625
2.50%
M****** T*******
€625
2.50%

News & Media Coverage

Insolvency Notices

Current insolvency proceedings

Check if there are any insolvency proceedings for this company

Commercial Register Documents

Shareholder List
Current Print (Aktueller Abdruck)
Chronological Print (Chronologischer Abdruck)

Organizations at this Address

77 nearby organizations

List of companies and organizations located at or near this business address. Data includes company names, addresses, registration details, and industry classifications.
The information on this page is sourced from public sources, official registries, or provided by third-party providers. Fusionbase does not guarantee the accuracy, completeness, or timeliness of the data. If you have any questions or suggestions, feel free to contact us via the contact form.